State Street
MPLT icon

State Street’s MapLight Therapeutics MPLT Stock Holding History

State Street’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.2M Sell
313,586
-538,564
-63% -$10.1M ﹤0.01% 3252
2026
Q2 		$30.5M Buy
852,150
+513,034
+151% +$14.8M ﹤0.01% 2161
2026
Q1 		$6.89M Buy
339,116
+109,632
+48% +$1.96M ﹤0.01% 2802
2025
Q4 		$4.03M Buy
+229,484
New +$3.84M ﹤0.01% 3086

Other funds holding MPLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

State Street's MPLT Position: Q3 2026 in Review

State Street reduced its MapLight Therapeutics (MPLT) stake by 63% in Q3 2026, selling an estimated $10.1M and leaving 313,586 shares worth $3.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

State Street first reported a position in MPLT in Q4 2025 and has held it in 4 quarters since. The position peaked at $30.5M in Q2 2026. 42 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • State Street held 313,586 shares of MapLight Therapeutics worth $3.2M as of Q3 2026.
  • State Street sold 538,564 MapLight Therapeutics shares in Q3 2026, an estimated $10.1M.
  • MapLight Therapeutics made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3252 holding.
  • State Street first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • State Street's MapLight Therapeutics position peaked at $30.5M in Q2 2026.
  • 42 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.